Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1969 1
1970 1
1971 2
1972 2
1973 1
1974 2
1975 1
1976 2
1977 2
1978 1
1979 2
1980 1
1981 2
1982 2
1983 1
1985 2
1986 1
1988 1
1990 1
1998 1
2000 5
2001 3
2002 3
2003 2
2004 1
2005 5
2007 1
2008 3
2009 9
2010 5
2011 7
2012 3
2013 9
2014 7
2015 6
2016 10
2017 11
2018 9
2019 12
2020 16
2021 14
2022 10
2023 14
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Behavioral Motor Performance.
Leib R, Howard IS, Millard M, Franklin DW. Leib R, et al. Among authors: millard m. Compr Physiol. 2023 Dec 29;14(1):5179-5224. doi: 10.1002/cphy.c220032. Compr Physiol. 2023. PMID: 38158372
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis.
Moulin D, Millard M, Taïeb M, Michaudel C, Aucouturier A, Lefèvre A, Bermúdez-Humarán LG, Langella P, Sereme Y, Wanherdrick K, Gautam P, Mariette X, Dieudé P, Gottenberg JE, Jouzeau JY, Skurnik D, Emond P, Mulleman D, Sellam J, Sokol H. Moulin D, et al. Among authors: millard m. Ann Rheum Dis. 2024 Feb 15;83(3):312-323. doi: 10.1136/ard-2023-224014. Ann Rheum Dis. 2024. PMID: 38049981 Free PMC article.
What Do the Guidelines Really Say About Aspirin?
Millard MA, Hernandez-Vila EA. Millard MA, et al. Tex Heart Inst J. 2018 Aug 1;45(4):228-230. doi: 10.14503/THIJ-18-6673. eCollection 2018 Aug. Tex Heart Inst J. 2018. PMID: 30374231 Free PMC article. Review. No abstract available.
Child With Arm Pain.
Millard M, Hu E, Le J. Millard M, et al. Ann Emerg Med. 2023 Jul;82(1):82-100. doi: 10.1016/j.annemergmed.2023.01.025. Ann Emerg Med. 2023. PMID: 37349073 No abstract available.
Integrin targeted therapeutics.
Millard M, Odde S, Neamati N. Millard M, et al. Theranostics. 2011 Feb 17;1:154-88. doi: 10.7150/thno/v01p0154. Theranostics. 2011. PMID: 21547158 Free PMC article.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
Update on PET Tracer Development for Muscarinic Acetylcholine Receptors.
Ozenil M, Aronow J, Millard M, Langer T, Wadsak W, Hacker M, Pichler V. Ozenil M, et al. Among authors: millard m. Pharmaceuticals (Basel). 2021 Jun 2;14(6):530. doi: 10.3390/ph14060530. Pharmaceuticals (Basel). 2021. PMID: 34199622 Free PMC article. Review.
191 results